SWX/NVAX (SWX/NVAX)

SIX Swiss Exchange: SWX/NVAX · CHF

CHF 8.00

-0.37 (-4.4%)· Recorded snapshot

Market cap	1.3B
Revenue (ttm)	334.3M
Net income (ttm)	-200.2M
EPS (ttm)	-CHF 1.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 334.3M
Net income (ttm): -200.2M
EPS (ttm): -CHF 1.24
Market cap: 1.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-18

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/NVAX indicators

Market & fundamental data

Available fields

152

Groups with data

Currency

USD

Showing 152 of 152 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	United States
Country code	CH
Earnings date	2026-11-05
Employees	749
Employees change	-203
Employees growth	-21.32%
Enterprise value	CHF 942.1M
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	1987
Industry	Biotechnology
Is primary listing	No
ISIN number	US6700024010
Last refreshed	2026-11-03
Market cap	CHF 1.3B
Next earnings date	2026-11-05
Price	CHF 8.00
Price currency	CHF
Sector	Healthcare
SIC code	2836
Stock price date	2026-11-02
Symbol	swx/NVAX
Website	https://www.novavax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-15.57%
EV/Sales	2.78x
FCF / EV yield	-3.62%
FCF yield	-2.65%
Industry forward P/E	85.45x
P/S ratio	3.85x
Sector forward P/E	19.93x
Sector P/E	34.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-28.85%
EBITDA margin	-24.54%
Gross margin	-2.56%
Operating margin	-28.85%
Pretax margin	-59.28%
Profit margin	-59.87%
Profit per employee	CHF -267,244
Profitable years	1
Revenue per employee	CHF 446,391
ROA	-6.51%
ROA (5Y)	-13.46%
ROCE	-19.1%
ROIC	-18.01%
SBC / revenue	7.81%
Tax / revenue	0.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Net income growth years	4
Revenue growth	-61.64%
Revenue growth (Q)	-76.3%
Revenue growth (QoQ)	-59.36%
Revenue growth 10Y	36.01%
Revenue growth 3Y	-36.25%
Revenue growth 5Y	-18.93%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -4.3M
Depreciation and amortization	CHF 14.6M
EBIT	CHF -96.5M
EBITDA	CHF -82.1M
EPS	CHF -1.24
Financing cash flow	CHF 60.4M
Free cash flow	CHF -34.1M
Free cash flow minus SBC	CHF -60.2M
Gross profit	CHF -8.6M
Income taxes	CHF 2M
Investing cash flow	CHF -88.5M
Net borrowing	CHF 66.1M
Net cash flow	CHF -58.9M
Net income	CHF -200.2M
Operating cash flow minus SBC	CHF -55.9M
Operating income	CHF -96.5M
Revenue	CHF 334.3M
Stock-based compensation	CHF 26.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-5.5
Book value per share	CHF -0.93
Goodwill	CHF 92.3M
Interest coverage	-5.2
Long-term assets	CHF 139.9M
Long-term liabilities	CHF 655.2M
Net cash (debt)	CHF 341M
Net cash / market cap	26.48%
Net cash growth	9.95%
Piotroski F-Score	1
Property, plant and equipment	CHF 47.5M
Shareholders' equity	CHF -154.1M
Tangible book value	CHF -245M
Tangible book value per share	CHF -1.49
Total assets	CHF 772.1M
Total cash	CHF 581.2M
Total debt	CHF 240.2M
Total liabilities	CHF 926.2M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.36
Current assets	CHF 632.2M
Current liabilities	CHF 271M
Current ratio	2.33
Inventory turnover	41.92
Net working capital	CHF -222M
Quick ratio	2.23
Working capital	CHF 355.9M
Working capital turnover	0.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.06%
Shareholder yield	3.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CHF 7.51
1D price change	-4.39%
1M price change	-7.09%
1M total return	-7.09%
1W price change	6.32%
1W total return	6.32%
20-day SMA	CHF 9.17
200-day SMA	CHF 7.46
3M price change	40.33%
3M total return	40.33%
50-day SMA	CHF 8.60
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 10.82
52-week high date	2026-10-15
52-week low	CHF 5.11
52-week low date	2025-12-16
6M price change	31.27%
6M total return	31.27%
All-time high	CHF 10.82
All-time high date	2026-10-15
All-time low	CHF 5.11
All-time low date	2025-12-16
Average true range (ATR)	CHF 0.29
Average volume	0
Change from 52-week high	-26.08%
Change from 52-week low	56.46%
Change from all-time high	-22.69%
Change from all-time low	63.64%
Monthly RSI	0
Previous close	CHF 8.36
Price vs 150-day SMA	11.42%
Price vs 20-day SMA	-8.82%
Price vs 200-day SMA	12.08%
Price vs 50-day SMA	-2.74%
RSI	40.08
Sharpe ratio	0.92
Sortino ratio	1.62
Weekly RSI	51.73
YTD price change	55.43%
YTD total return	55.43%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	146.2M
Shares change (QoQ)	0.79%
Shares change (YoY)	-3.06%
Shares held by insiders	0.79%
Shares held by institutions	58.89%
Short ratio	7.5 days

Deeper analysis on SWX/NVAX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/NVAX report

Is a complete SWX/NVAX research report available?

No complete published report is available for swx/NVAX (SWX/NVAX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/NVAX (SWX/NVAX)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/NVAX

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All SWX/NVAX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/NVAX

Frequently asked questions